281-296-7300

  • Awards
  • Careers
logo
  • About
    • About VGXI
    • Leadership
    • VGXI Mission
    • Awards
    • Careers
  • Services
    • Manufacturing Services
    • cGMP Plasmid
    • HD Plasmid
    • Pre-Clinical Plasmid
    • Additional Services
  • VGXI Process
    • VGXI Manufacturing Process
    • Analytical Testing
    • Quality Systems
  • Resource Center
    • News
    • Events
    • FAQs
    • Whitepapers
    • Posters & Presentations
  • Contact Us
  • Awards
  • Careers

A DNA Vaccine for Breast Cancer

A DNA Vaccine for Breast Cancer

November 11, 2011

According to Science Daily a research group at Karolinska Institutet has developed a DNA-vaccine against DLL4 (a protein which has recently been identified as an important component in regulating the formation of new blood vessels) and the blood vessel tip cells.

They have shown that the vaccination against DLL4 causes an immunological antibody response to DLL4, which hinders the growth of breast cancer in mice. Tumors from the vaccinated mice had a tightly packed network of non-functional blood vessels, and poor blood supply.

The vaccination did not cause any undesired effects and did not affect the animal’s capacity for wound healing.

 

Filed Under: Blog, Uncategorized

Archives

  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012
  • 2011
  • 2010
  • 2009
  • 2008
  • 2007
  • About
  • Services
  • VGXI Process
  • Contact Us
  • Careers
  • Awards
  • Resource Center
logo white

281-296-7300
2700 Research Forest Drive, Suite 180
The Woodlands, Texas 77381, USA

Teko Font
Please enter your name.
Please enter a valid email address.
Sign Up

Thanks for subscribing! Please check your email for further instructions.

Something went wrong. Please check your entries and try again.

© 2021 VGXI, Inc. All Rights Reserved.Terms | Privacy Policy